{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:39:24Z","timestamp":1794613164554,"version":"4.9.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>There is a paucity of information concerning the short- and long-term benefits and harm of antenatal corticosteroid administration and of expanded corticosteroid administration with dexamethasone in the late preterm period. Thus, we aimed to compare the effect on short-term respiratory complications, hypoglycemia, and long-term neurodevelopmental disorders in neonates born in the late preterm period between cases with and without corticosteroid administration and evaluate the difference in effects according to the type of corticosteroid administered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective observational cohort study included all women who had a singleton delivery in the late preterm period between January 2007 and December 2015. We extracted data from Korea National Health Insurance claims and National Health Screening Program for Infants and Children databases. Primary short-term outcomes were in the late preterm period. Concerning short-term effectiveness for respiratory morbidity, dexamethasone administration in the late preterm period was associated with respiratory complications and hypoglycemia in neonates. Long-term outcomes were neurodevelopmental disorders in infants\/children observed at follow-up among all neonates until the end of 2018.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 57,963 women who delivered late preterm births during the study period, 1,255 (2.2%) had received antenatal corticosteroid administration in late preterm period. Dexamethasone administration was associated with a decreased risk of transient tachypnea (adjusted odds ratio [aOR] 0.66, 95% confidence interval [CI] 0.50\u20130.88) compared with no antenatal corticosteroid administration, but this effect was not observed in relation to betamethasone administration (aOR 0.69, 95% CI 0.42\u20131.14).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Dexamethasone administration in late preterm infants was associated with a decreased risk of transient tachypnea compared with no corticosteroid administration but this effect was not observed with betamethasone administration. However, antenatal corticosteroid administration in the late preterm period did not lower the risk of other respiratory complications nor increase the risk of hypoglycemia, with no effect on neurodevelopment regardless of the type used.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12884-024-06851-y","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T10:01:01Z","timestamp":1739354461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A comparison of short- and long-term prognoses between cases with and without antenatal corticosteroid administration in late preterm delivery: a nationwide population-based study"],"prefix":"10.1186","volume":"25","author":[{"given":"Geum Joon","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Wook","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Dong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sungyeon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk-Joo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jeong","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"6851_CR1","first-page":"CD004454","volume":"3","author":"D Roberts","year":"2006","unstructured":"Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;3:CD004454.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"6851_CR2","first-page":"CD004454","volume":"2017","author":"D Roberts","year":"2017","unstructured":"Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;2017(3):CD004454.","journal-title":"Cochrane Database Syst Rev"},{"key":"6851_CR3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/AOG.0000000000002231","volume":"130","author":"American College of Obstetricians and Gynecologists Committee Opinion Number 713","year":"2017","unstructured":"American College of Obstetricians and Gynecologists Committee Opinion Number 713. Antenatal corticosteroid therapy for fetal lung maturation. August 2017. Obstet Gynecol. 2017;130:493\u20134.","journal-title":"Obstet Gynecol"},{"key":"6851_CR4","doi-asserted-by":"crossref","unstructured":"Committee on Obstetric Practice. Committee Opinion No. 713: Antenatal corticosteroid therapy for fetal maturation. Obstet Gynecol. 2017;130:e102-9.","DOI":"10.1097\/AOG.0000000000002237"},{"key":"6851_CR5","doi-asserted-by":"publisher","first-page":"B13","DOI":"10.1016\/j.ajog.2016.03.013","volume":"215","author":"Society for Maternal-Fetal Medicine (SMFM) Publications Committee","year":"2016","unstructured":"Society for Maternal-Fetal Medicine (SMFM) Publications Committee. Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery. Am J Obstet Gynecol. 2016;215:B13\u201315.","journal-title":"Am J Obstet Gynecol"},{"key":"6851_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1001\/jama.284.7.843","volume":"284","author":"MS Kramer","year":"2000","unstructured":"Kramer MS, Demissie K, Yang H, Platt RW, Sauv\u00e9 R, Liston R. The contribution of mild and moderate preterm birth to infant mortality. Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. JAMA. 2000;284:843\u20139.","journal-title":"JAMA"},{"key":"6851_CR7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1542\/peds.114.2.372","volume":"114","author":"ML Wang","year":"2004","unstructured":"Wang ML, Dorer DJ, Fleming MP, Catlin EA. Clinical outcomes of near-term infants. Pediatrics. 2004;114:372\u20136.","journal-title":"Pediatrics"},{"key":"6851_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1053\/j.semperi.2006.01.005","volume":"30","author":"GJ Escobar","year":"2006","unstructured":"Escobar GJ, Clark RH, Greene JD. Short-term outcomes of infants born at 35 and 36 weeks\u2019 gestation: we need to ask more questions. Semin Perinatol. 2006;30:28\u201333.","journal-title":"Semin Perinatol"},{"key":"6851_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/01.AOG.0000297311.33046.73","volume":"111","author":"DD McIntire","year":"2008","unstructured":"McIntire DD, Leveno KJ. Neonatal mortality and morbidity rates in late preterm births compared with births at term. Obstet Gynecol. 2008;111:35\u201341.","journal-title":"Obstet Gynecol"},{"key":"6851_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jama.2010.1015","volume":"304","author":"JU Hibbard","year":"2010","unstructured":"Hibbard JU, Wilkins I, Sun L, et al. Respiratory morbidity in late preterm births. JAMA. 2010;304:419\u201325.","journal-title":"JAMA"},{"key":"6851_CR11","doi-asserted-by":"crossref","unstructured":"Porto AM, Coutinho IC, Correia JB, Amorim MM. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial. BMJ 2011.","DOI":"10.1097\/OGX.0b013e31823520c2"},{"key":"6851_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000295898","volume":"70","author":"O Balci","year":"2010","unstructured":"Balci O, Ozdemir S, Mahmoud AS, Acar A, Colakoglu MC. The effect of antenatal steroids on fetal lung maturation between the 34th and 36th week of pregnancy. Gynecol Obstet Invest. 2010;70:95\u20139.","journal-title":"Gynecol Obstet Invest"},{"key":"6851_CR13","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","volume":"374","author":"C Gyamfi-Bannerman","year":"2016","unstructured":"Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. Antenatal betamethasone for women at risk for late preterm delivery. N Engl J Med. 2016;374:1311\u201320.","journal-title":"N Engl J Med"},{"key":"6851_CR14","doi-asserted-by":"publisher","first-page":"i5044","DOI":"10.1136\/bmj.i5044","volume":"355","author":"G Saccone","year":"2016","unstructured":"Saccone G, Berghella V. Antenatal corticosteroids for maturity of term or near-term fetuses: systematic review and meta-analysis of randomized controlled trials. BMJ. 2016;355:i5044.","journal-title":"BMJ"},{"key":"6851_CR15","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1080\/14767058.2018.1554051","volume":"33","author":"M Mirzamoradi","year":"2020","unstructured":"Mirzamoradi M, Hasani Nejhad F, Jamali R, Heidar Z, Bakhtiyari M. Evaluation of the effect of antenatal betamethasone on neonatal respiratory morbidities in late preterm deliveries (34\u201337 weeks). J Matern Fetal Neonatal Med. 2020;33:2533\u201340.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"6851_CR16","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/tropej\/fmy001","volume":"64","author":"V Ontela","year":"2018","unstructured":"Ontela V, Dorairajan G, Bhat VB, Chinnakali P. Effect of antenatal steroids on respiratory morbidity of late preterm newborns: a randomized controlled trial. J Trop Pediatr. 2018;64:531\u20138.","journal-title":"J Trop Pediatr"},{"key":"6851_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jogc.2016.05.011","volume":"39","author":"CM Nowik","year":"2017","unstructured":"Nowik CM, Davies GA, Smith GN. We should proceed with caution when it comes to antenatal corticosteroids after 34 weeks. J Obstet Gynaecol Can. 2017;39:49\u201351.","journal-title":"J Obstet Gynaecol Can"},{"key":"6851_CR18","first-page":"CD006764","volume":"8","author":"FC Brownfoot","year":"2013","unstructured":"Brownfoot FC, Gagliardi DI, Bain E, Middleton P, Crowther CA. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2013;8:CD006764.","journal-title":"Cochrane Database Syst Rev"},{"key":"6851_CR19","first-page":"25","volume":"23","author":"N Attawattanakul","year":"2015","unstructured":"Attawattanakul N, Tansuspswatdikul P. Effect of antenatal dexamethasone on respiratory distress in late preterm infant: a randomized controlled trial. Thai J Obstet Gynecol. 2015;23:25\u201333.","journal-title":"Thai J Obstet Gynecol"},{"key":"6851_CR20","first-page":"103","volume":"28","author":"A Waiketkarn","year":"2020","unstructured":"Waiketkarn A, Somprasit C, Tanprasertkul C. The effect of single dose antenatal dexamethasone in reducing respiratory complications in late preterm. Thai J Obstet Gynecol. 2020;28:103\u201311.","journal-title":"Thai J Obstet Gynecol"},{"key":"6851_CR21","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12884-024-06304-6","volume":"24","author":"KA Shittu","year":"2024","unstructured":"Shittu KA, Ahmed B, Rabiu KA, Akinlusi F, Akinola OI. Does the use of antenatal corticosteroids reduce respiratory morbidity in babies born in late preterm period? BMC Pregnancy Childbirth. 2024;24:334.","journal-title":"BMC Pregnancy Childbirth"},{"key":"6851_CR22","first-page":"1","volume":"64","author":"JA Martin","year":"2015","unstructured":"Martin JA, Hamilton BE, Osterman MJ, Curtin SC, Matthews TJ. Births: final data for 2013. Natl Vital Stat Rep. 2015;64:1\u201365.","journal-title":"Natl Vital Stat Rep"},{"key":"6851_CR23","doi-asserted-by":"publisher","first-page":"xix","DOI":"10.1016\/j.clp.2013.07.013","volume":"40","author":"L Jain","year":"2013","unstructured":"Jain L, Raju TN. Late preterm and early term births. Clin Perinatol. 2013;40:xix\u2013xx.","journal-title":"Clin Perinatol"},{"key":"6851_CR24","doi-asserted-by":"publisher","first-page":"e4611","DOI":"10.1016\/j.ajog.2017.04.029","volume":"217","author":"V Souter","year":"2017","unstructured":"Souter V, Kauffman E, Marshall AJ, Katon JG. Assessing the potential impact of extending antenatal steroids to the late preterm period. Am J Obstet Gynecol. 2017;217:e4611\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"6851_CR25","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1097\/AOG.0000000000000748","volume":"125","author":"A Sotiriadis","year":"2015","unstructured":"Sotiriadis A, Tsiami A, Papatheodorou S, Baschat AA, Sarafidis K, Makrydimas G. Neurodevelopmental outcome after a single course of antenatal steroids in children born preterm: a systematic review and meta-analysis. Obstet Gynecol. 2015;125:1385\u201396.","journal-title":"Obstet Gynecol"},{"key":"6851_CR26","doi-asserted-by":"publisher","first-page":"F195","DOI":"10.1136\/archdischild-2012-303157","volume":"98","author":"PR Stutchfield","year":"2013","unstructured":"Stutchfield PR, Whitaker R, Gliddon AE, Hobson L, Kotecha S, Doull IJ. Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial). Arch Dis Child Fetal Neonatal Ed. 2013;98:F195\u2013200.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"6851_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/bmj.38576.494363.E0","volume":"331","author":"SR Dalziel","year":"2005","unstructured":"Dalziel SR, Lim VK, Lambert A, et al. Antenatal exposure to betamethasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ. 2005;331:665.","journal-title":"BMJ"},{"key":"6851_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1055\/s-2007-1022470","volume":"25","author":"G Ventolini","year":"2008","unstructured":"Ventolini G, Neiger R, Mathews L, Adragna N, Belcastro M. Incidence of respiratory disorders in neonates born between 34 and 36 weeks of gestation following exposure to antenatal corticosteroids between 24 and 34 weeks of gestation. Am J Perinatol. 2008;25:79\u201383.","journal-title":"Am J Perinatol"},{"key":"6851_CR29","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.ajog.2005.06.050","volume":"193","author":"AM Peaceman","year":"2005","unstructured":"Peaceman AM, Bajaj K, Kumar P, Grobman WA. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes. Am J Obstet Gynecol. 2005;193:1165\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"6851_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jpeds.2011.12.047","volume":"161","author":"EWY Tam","year":"2012","unstructured":"Tam EWY, Haeusslein LA, Bonifacio SL, et al. Hypoglycemia is associated with increased risk for brain injury and adverse neurodevelopmental outcome in neonates at risk for encephalopathy. J Pediatr. 2012;161:88\u201393.","journal-title":"J Pediatr"},{"key":"6851_CR31","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jpeds.2009.06.044","volume":"155","author":"WW Hay Jr","year":"2009","unstructured":"Hay WW Jr, Raju TN, Higgins RD, Kalhan SC, Devaskar SU. Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia: workshop report from Eunice Kennedy Shriver National Institute of Child Health and Human Development. J Pediatr. 2009;155:612\u20137.","journal-title":"J Pediatr"},{"key":"6851_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.siny.2013.09.003","volume":"19","author":"W Tin","year":"2014","unstructured":"Tin W. Defining neonatal hypoglycaemia: a continuing debate. Semin Fetal Neonatal Med. 2014;19:27\u201332.","journal-title":"Semin Fetal Neonatal Med"},{"key":"6851_CR33","first-page":"118","volume-title":"Strategies to improve the validity of diagnostic codes of National Health Insurance claims data","author":"BJ Park","year":"2002","unstructured":"Park BJ, Sung JH, Park KD, Seo SW, Kim SW. Strategies to improve the validity of diagnostic codes of National Health Insurance claims data. Seoul: Health Insurance Review and Assessment Services; 2002. pp. 118\u20139."},{"key":"6851_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejogrb.2006.05.006","volume":"131","author":"S Costa","year":"2007","unstructured":"Costa S, Zecca E, De Luca D, De Carolis MP, Romagnoli C. Efficacy of a single dose of antenatal corticosteroids on morbidity and mortality of preterm infants. Eur J Obstet Gynecol Reprod Biol. 2007;131:154\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"6851_CR35","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1080\/01443610500314827","volume":"25","author":"D Ogunyemi","year":"2005","unstructured":"Ogunyemi D. A comparison of the effectiveness of single-dose vs. multi-dose antenatal corticosteroids in pre-term neonates. J Obstet Gynaecol. 2005;25:756\u201360.","journal-title":"J Obstet Gynaecol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-06851-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-024-06851-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-024-06851-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T10:59:02Z","timestamp":1740394742000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-024-06851-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6851"],"URL":"https:\/\/doi.org\/10.1186\/s12884-024-06851-y","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"11 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was also approved by the Institutional Review Board of the Korean University Guro Hospital. This study was undertaken in accordance with the Declaration of Helsinki. Anonymized and deidentified participant data were used for analysis; therefore, the requirement for informed consent or parental permission was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}